Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Cogent Biosciences Inc (COGT)

Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Cogent Biosciences Announces Updated Clinical Results from SUMMIT, Showcasing Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients GlobeNewswire - Mon Dec 9, 6:00AM CST

COGT : 7.84 (+0.51%)
Cogent Biosciences Reports Promising APEX Phase 2 Trial Results for Bezuclastinib in Advanced Systemic Mastocytosis at ASH 2024 Quiver Quantitative, Inc. - Sun Dec 8, 9:22PM CST

Cogent Biosciences reports promising APEX clinical trial results for bezuclastinib in advanced systemic mastocytosis, with significant response rates.Quiver AI SummaryCogent Biosciences, Inc. announced...

COGT : 7.84 (+0.51%)
Cogent Biosciences Announces Positive Updated Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM) GlobeNewswire - Sun Dec 8, 11:00AM CST

COGT : 7.84 (+0.51%)
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2024 Financial Results GlobeNewswire - Tue Nov 12, 7:00AM CST

COGT : 7.84 (+0.51%)
Cogent Biosciences Announces Bezuclastinib Presentations at the 66th Annual American Society of Hematology (ASH) Meeting GlobeNewswire - Tue Nov 5, 8:00AM CST

COGT : 7.84 (+0.51%)
Cogent Biosciences Announces Pipeline Expansion into KRAS and Poster Presentations at the 2024 EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics GlobeNewswire - Wed Oct 23, 6:00AM CDT

COGT : 7.84 (+0.51%)
Wall Street - Tall Buildings in New York City -J4M9FKPEaUA-unsplash
Markets Today: Stocks Slightly Higher on Strength in Tesla and Netflix Barchart - Wed Jun 7, 2023

Morning Markets June E-Mini S&P 500 futures (ESM2 3) this morning are up +0.09%, and June Nasdaq 100 E-Mini futures (NQM2 3) are up +0.11%. U.S. stock index futures this morning are slightly higher. Tesla...

ESH25 : 6,001.75s (+1.14%)
NQH25 : 21,566.50s (+0.88%)
TSLA : 421.06 (-3.46%)
NFLX : 909.05 (+0.78%)
PLAY : 27.40 (+4.58%)
AMZN : 224.92 (+0.73%)
YEXT : 6.38 (+0.31%)
SMCI : 31.59 (+1.12%)
NVCR : 30.80 (+1.32%)
CASY : 403.16 (-1.46%)
BASE : 15.44 (+0.39%)
UNFI : 25.88 (-1.26%)
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2022 Financial Results Globe Newswire - Tue Aug 9, 2022

On-track to present additional data from Phase 2 APEX trial by the end of 2022 Initial data from Phase 2 SUMMIT trial & lead-in data from Phase 3...

COGT : 7.84 (+0.51%)
Cogent Biosciences Announces Closing of Upsized Public Offering of Common Stock and Pre-funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares Globe Newswire - Thu Jun 16, 2022

CAMBRIDGE, Mass. and BOULDER, Colo., June 16, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on...

COGT : 7.84 (+0.51%)
Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock and Pre-funded Warrants Globe Newswire - Mon Jun 13, 2022

CAMBRIDGE, Mass. and BOULDER, Colo., June 13, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on...

COGT : 7.84 (+0.51%)

Barchart Exclusives

How To Profit From The Latest Corporate Spinoffs: A Guide For Investors In 2025 Barchart - 47 minutes ago
How to navigate corporate spinoffs. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot